T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.4% |
| 2 | Healthcare | 16.1% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTTR
1826
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $1.48M | ﹤0.01% |
71,520
+60,670
| +559% | +$1.39M |
|
1827
Viasat
VSAT
$11.2B
| $1.47M | ﹤0.01% |
33,019
-2,074
| -6% | -$107K |
|
1828
Evercore
EVR
$11.9B
| $1.47M | ﹤0.01% |
10,801
-1,283
| -11% | -$187K |
|
1829
NIO
NIO
$11.3B
| $1.47M | ﹤0.01% |
46,300
| – | – |
|
1830
RLJ Lodging Trust
RLJ
$1.68B
| $1.46M | ﹤0.01% |
105,099
-23,097
| -18% | -$325K |
|
1831
Group 1 Automotive
GPI
$3.11B
| $1.46M | ﹤0.01% |
7,490
-707
| -9% | -$137K |
|
1832
Edgewell Personal Care
EPC
$1.32B
| $1.46M | ﹤0.01% |
31,860
-1,753
| -5% | -$70.7K |
|
1833
Plexus
PLXS
$7.06B
| $1.45M | ﹤0.01% |
15,163
-947
| -6% | -$87.4K |
|
1834
Tenaris
TS
$27.1B
| $1.45M | ﹤0.01% |
69,700
-5,535,483
| -99% | -$121M |
|
1835
Check Point Software Technologies
CHKP
$13.5B
| $1.45M | ﹤0.01% |
12,469
-2,104
| -14% | -$244K |
|
1836
Rithm Capital
RITM
$5.81B
| $1.45M | ﹤0.01% |
135,212
-10,122
| -7% | -$113K |
|
1837
Apogee Enterprises
APOG
$883M
| $1.45M | ﹤0.01% |
30,060
-437
| -1% | -$19.1K |
|
1838
NetEase
NTES
$80B
| $1.45M | ﹤0.01% |
14,220
| – | – |
|
|
CSGS
1839
DELISTED
CSG Systems International
CSGS
| $1.44M | ﹤0.01% |
25,064
-740
| -3% | -$39.2K |
|
1840
Granite Construction
GVA
$5.53B
| $1.44M | ﹤0.01% |
37,181
-800
| -2% | -$31.7K |
|
1841
National Health Investors
NHI
$3.58B
| $1.44M | ﹤0.01% |
25,040
-3,366
| -12% | -$186K |
|
1842
Fidelity MSCI Health Care Index ETF
FHLC
$3.4B
| $1.44M | ﹤0.01% |
20,944
| – | – |
|
1843
Itron
ITRI
$4.47B
| $1.44M | ﹤0.01% |
20,966
-5,986
| -22% | -$421K |
|
|
HTLF
1844
DELISTED
Heartland Financial USA, Inc.
HTLF
| $1.44M | ﹤0.01% |
28,363
+731
| +3% | +$36.8K |
|
|
ARGO
1845
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $1.44M | ﹤0.01% |
24,698
-2
| -0% | -$113 |
|
1846
Gray Television
GTN
$532M
| $1.43M | ﹤0.01% |
71,040
+11,495
| +19% | +$254K |
|
1847
Calix
CALX
$2.5B
| $1.43M | ﹤0.01% |
17,842
-892
| -5% | -$58.2K |
|
1848
MACOM Technology Solutions
MTSI
$23.6B
| $1.41M | ﹤0.01% |
18,044
-2,012
| -10% | -$145K |
|
|
B
1849
DELISTED
Barnes Group Inc.
B
| $1.41M | ﹤0.01% |
30,242
-7,865
| -21% | -$348K |
|
|
ACH
1850
Accendra Health
ACH
$81.5M
| $1.41M | ﹤0.01% |
32,330
-4,465
| -12% | -$175K |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.